 |
| Staff at the Central Zoo conduct disinfection work to curb the current COVID-19 health crisis in Pyongyang in this undated photo released by the official North Korean Central News Agency (KCNA), May 20. North Korea has reported that the number of people with COVID-19 symptoms has risen past 2 million since the country first disclosed an outbreak last week, according to the KCNA. EPA-Yonhap |
North Korea reported over 134,510 new suspected COVID-19 cases Tuesday, with the total number of cases of "fever" reaching nearly 3 million.
More than 134,510 people showed indications of fever, with no additional deaths reported, over a 24-hour period until 6 p.m. the previous day, the official Korean Central News Agency (KCNA) reported, citing data from the state emergency epidemic prevention headquarters.
The daily number of fever cases has remained below 200,000 for the third consecutive day after reaching 219,030 cases Saturday.
The death toll remains at 68, with the fatality rate standing at 0.002 percent, the KCNA said.
North Korea's media shifts stance, questions effectiveness of COVID-19 vaccines 2022-05-24 11:35 | North Korea
The fever caseload reported since late April in the nation, with a population of 24 million, came to more than 2.94 million as of 6 p.m. Sunday, of which more than 2.54 million, have recovered and at least 400,230 are being treated, it added.
The KCNA stressed that the North has succeeded in effectively keeping the virus situation under control.
"In a few days after the maximum emergency epidemic prevention system was activated, the nation-wide morbidity and mortality rates have drastically decreased and the number of recovered persons increased, resulting in effectively curbing and controlling the spread of the pandemic disease and maintaining the clearly stable situation," it said.
Public health institutes in the North are currently conducting a reinvestigation into "fevered and recovered" patients across the country to analyze the coronavirus, including its latent period, symptoms, recurrence rate and reaction to medicine.
Pyongyang has also boosted the production capacity of its pharmaceutical industry to ensure a better supply of medicine to its people, the KCNA said.
On May 12, North Korea reported its first COVID-19 case after claiming to be coronavirus-free for over two years and declared the implementation of a "maximum emergency" virus control system.
The reclusive North continues to remain unresponsive to South Korea's offer of COVID-19 assistance. (Yonhap)
